The FTC wins a legal battle as court rejects PBMs' challenge over insulin pricing deals, ending a key antitrust dispute.
CMS recalculates Medicare star ratings post-Clover loss, impacting insurers' bids and bonus payments for 2026 Medicare Advantage plans.